2-(4-iodophenyl)-6-methoxy-1,3-benzothiazole | 1206189-72-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 英文名称: 2-(4-iodophenyl)-6-methoxy-1,3-benzothiazole
• CAS: 1206189-72-1
• 化学式: C₁₄H₁₀INOS
• 分子量: 367.21
• InChiKey: RIWXPPTUZYKYCS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  18
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  50.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(4-iodophenyl)-6-methoxy-1,3-benzothiazole 在 三溴化硼 、 水 、 碳酸氢钠 作用下， 以 二氯甲烷 为溶剂， 反应 24.0h， 以55.8%的产率得到2-(4-iodophenyl)-1,3-benzothiazol-6-ol
  参考文献：
  名称：

  [EN] NUCLEOPHILIC FLUORINATION OF AROMATIC COMPOUNDS
  [FR] FLUORATION NUCLÉOPHILE DE COMPOSÉS AROMATIQUES

  摘要：

  公开号：

  WO2010008522A3
• 作为产物：
  描述：

  对碘氯苄 、 2-氨基-5-甲氧基苯硫酚 以 甲苯 为溶剂， 反应 1.0h， 以40%的产率得到2-(4-iodophenyl)-6-methoxy-1,3-benzothiazole
  参考文献：
  名称：

  [EN] NUCLEOPHILIC FLUORINATION OF AROMATIC COMPOUNDS
  [FR] FLUORATION NUCLÉOPHILE DE COMPOSÉS AROMATIQUES

  摘要：

  公开号：

  WO2010008522A3

文献信息

• NUCLEOPHILIC FLUORINATION OF AROMATIC COMPOUNDS
  申请人：Satyamurthy Nagichettiar

  公开号：US20110178302A1

  公开（公告）日：2011-07-21

  Iodylbenzene derivatives substituted with electron donating as well as electron withdrawing groups on the aromatic ring are used as precursors in aromatic nucleophilic substitution reactions. The iodyl group (IO 2 ) is regiospecifically substituted by nucleophilic fluoride to provide the corresponding fluoroaryl derivatives. No-carrier-added [F-18]fluoride ion derived from anhydrous [F-18](F/Kryptofix, [F-18]CsF or a quaternary ammonium fluoride (e.g., Me 4 NF, Et 4 NF, n-Bu 4 NF, (PhCH 2 ) 4 NF) exclusively substitutes the iodyl moiety in these derivatives and provides high specific activity F-18 labeled fluoroaryl analogs. Iodyl derivatives of a benzothiazole analog and 6-iodyl-L-dopa derivatives have been synthesized as precursors and have been used in the preparation of no-carrier-added [F-18]fluorobenzothiazole as well as 6-[F-18]fluoro-L-dopa.

  取代了电子给予基团和电子吸引基团的碘苯衍生物在芳香族亲核取代反应中被用作前体。亚碘酰基团(IO2)被亲核氟以区域特异性取代，提供相应的氟芳基衍生物。无载体添加的[F-18]氟离子源自无水[F-18](F/Kryptofix、[F-18]CsF或季铵氟化物(例如Me4NF、Et4NF、n-Bu4NF、(PhCH2)4NF))，只取代这些衍生物中的亚碘酰基团，并提供高比活度的F-18标记的氟芳基类似物。苯并噻唑类似物和6-碘-L-多巴衍生物的亚碘衍生物已被合成为前体，并用于制备无载体添加的[F-18]氟苯并噻唑和6-[F-18]氟-L-多巴。
• Nucleophilic fluorination of aromatic compounds
  申请人：Satyamurthy Nagichettiar

  公开号：US08674101B2

  公开（公告）日：2014-03-18

  Iodylbenzene derivatives substituted with electron donating as well as electron withdrawing groups on the aromatic ring are used as precursors in aromatic nucleophilic substitution reactions. The iodyl group (IO2) is regiospecifically substituted by nucleophilic fluoride to provide the corresponding fluoroaryl derivatives. No-carrier-added [F-18]fluoride ion derived from anhydrous [F-18](F/Kryptofix, [F-18]CsF or a quaternary ammonium fluoride (e.g., Me4NF, Et4NF, n-Bu4NF, (PhCH2)4NF) exclusively substitutes the iodyl moiety in these derivatives and provides high specific activity F-18 labeled fluoroaryl analogs. Iodyl derivatives of a benzothiazole analog and 6-iodyl-L-dopa derivatives have been synthesized as precursors and have been used in the preparation of no-carrier-added [F-18]fluorobenzothiazole as well as 6-[F-18]fluoro-L-dopa.

  取代了电子给予和电子吸引基团的碘苯衍生物可用作芳香族亲核取代反应的前体。亚碘基团（IO2）被亲核性氟离子区域特异性地取代，从而提供相应的氟代芳基衍生物。无载体添加的[F-18]氟离子，可以从无水[F-18]（F/Kryptofix，[F-18]CsF或季铵氟化物（例如，Me4NF，Et4NF，n-Bu4NF，（PhCH2）4NF）中获得，它们仅取代这些衍生物中的亚碘基团，并提供高比活度的F-18标记的氟代芳基类似物。苯并噻唑类似物和6-碘-L-多巴衍生物的碘衍生物已合成为前体，并用于制备无载体添加的[F-18]氟代苯并噻唑以及6-[F-18]氟-L-多巴。
• ISOTOYPICALLY-LABELED BENZOTHIAZOLE COMPOUNDS AS IMAGING AGENTS FOR AMYLOIDOGENIC PROTEINS
  申请人：Klunk William E.

  公开号：US20090142269A1

  公开（公告）日：2009-06-04

  The present invention provides an isolated linezolid impurity, desfluoro linezolid, the preparation thereof and its use as a reference standard.

  本发明提供了一种分离的利奈唑酮杂质，去氟利奈唑酮，其制备方法及其用作参考标准的用途。
• US8674101B2
  申请人：——

  公开号：US8674101B2

  公开（公告）日：2014-03-18
• [EN] LIGANDS FOR AGGREGATED TAU MOLECULES<br/>[FR] LIGANDS POUR MOLÉCULES DE LA PROTÉINE TAU AGGLOMÉRÉES
  申请人：WISTA LAB LTD

  公开号：WO2010034982A1

  公开（公告）日：2010-04-01

  Provided are certain benzothiazole, imidazothiazole, imidazopyrimidine and imidazopyridine compounds, including, for example:formula (I) and pharmaceutically and physiologically acceptable salts, hydrates, and solvates thereof. Such compounds can be used as diagnostic ligands or labels of tau protein and PHF.